[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587393":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":42,"responsibleParty":65,"collaborators":26,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":26,"eligibilityCriteria":73,"healthyVolunteers":69,"sex":74,"minAge":75,"maxAge":26,"enrollmentInfo":76,"targetDuration":26,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"University Hospital Ostrava","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"VR Group","EXPERIMENTAL","In patients randomized in this study arm, a virtual reality device will be used during the subcutaneous port implantation procedure.",[13],"Procedure: Virtual reality intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Non-VR Group","ACTIVE_COMPARATOR","In patients randomized in this study arm, no virtual reality device will be used during the subcutaneous port implantation procedure.",[19],"Procedure: Standard Care (in control arm)",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Virtual reality intervention","A virtual reality device will be used in one study arm during the implantation of the subcutaneous port.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Standard Care (in control arm)","Patients in this study arm will receive standard care, without the use of VR.",[15],[32],{"name":33,"affiliation":5,"role":34},"Lukáš Knybel, Ing., PhD","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"Jiří Hynčica","CONTACT","0042059737","2587","jiri.hyncica@fno.cz",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":26,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"RECRUITING","Ostrava","Moravian-Silesian Region","70852","Czechia",{"type":50,"coordinates":51},"Point",[52,53],18.28204,49.83465,{"lat":53,"lon":52},[56,57,58,61,63],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},{"name":33,"role":34,"phone":26,"phoneExt":26,"email":26},{"name":59,"role":60,"phone":26,"phoneExt":26,"email":26},"Štefan Reguli, MD, PhD","SUB_INVESTIGATOR",{"name":62,"role":60,"phone":26,"phoneExt":26,"email":26},"Martin Palička, MD",{"name":64,"role":60,"phone":26,"phoneExt":26,"email":26},"Tomáš Blažek, MD, PhD",{"type":66,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100587393","utilization-of-virtual-reality-to-increase-comfort-and-reduce-procedural-distress-during-port-insertion-into-the-body-100587393",false,"NCT06927804","Utilization of Virtual Reality to Increase Comfort and Reduce Procedural Distress During Port Insertion Into the Body","Utilization of Virtual Reality to Support Patient Comfort and Reduce Stress During the Implantation of a Subcutaneous Venous Port Prior to the Initiation of Oncological Treatment","Inclusion Criteria:\n\n* Patients \\> 18 years of age\n* Signed Informed Consent Form\n* Patients Indicated for oncology treatment administration using subcutaneous port\n\nExclusion Criteria:\n\n* Not signing of the Informed Consent Form\n* Patients \\\u003C 18 years of age\n* Patients unsuitable for subcutaneous port implantation","ALL","18 Years",{"count":77,"type":78},60,"ESTIMATED","INTERVENTIONAL",[81],"NA","This randomised controlled study evaluates whether virtual reality (VR) can support patient comfort and help reduce anxiety and stress during subcutaneous venous port implantation in adult oncology patients. Patients will be assigned to standard care or standard care with VR intervention.\n\nSubjective and objective measures of stress and discomfort will be collected, including the Visual Analog Scale (VAS) for self-reported procedural discomfort, physiological parameters (blood pressure, heart rate, variability), the STAI-6 questionnaire, and salivary cortisol.\n\nThe study aims to explore the potential of VR as a non-pharmacological, immersive tool to improve procedural experience and reduce psychological distress in patients undergo-ing minor oncological procedures.",[84],"Oncology Patients",[86,87,88,89,90],"Virtual reality","subcutaneous venous port","anxiety","stress","pain","2025-12-12",{"date":93,"type":94},"2025-12-19","ACTUAL",{"date":96,"type":94},"2025-07-01",{"date":98,"type":78},"2026-12-31",{"name":5,"class":6},1]